NCT00579280 - Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD | Biotech Hunter

Enrollment

224

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Bipolar DisorderPanic DisorderGeneralized Anxiety Disorder

Interventions

DRUG

quetiapine SR

flexible dosing, 50 mg up to a maximum of 300 mg per day for 8 weeks

DRUG

divalproex sodium ER

Flexible dosing, 500 mg up to a maximum of 3000 mg per day for 8 weeks

DRUG

placebo

Trial Locations (3)

University of South Florida College of Medicine, Tampa

University of Cincinnati Medical Center, Cincinnati

VA Palo Alto HCS & Stanford School of Medicine, Palo Alto